Pylum Biosciences Collaborates on Research Published in the Journal Nature

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Pylum Biosciences, Inc., a biotechnology company developing a new class of precision antibacterial medicines, in collaboration with researchers at the University of California, Los Angeles and The University of Texas Medical Branch, today announced the publication of key structural mechanisms of action for a class of naturally occurring bacteria killers, R-type pyocins. Pioneering a New Class of Precision Antibiotics R-type pyocins are naturally occ

Click to view original post